Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × veltuzumab × Clear all

Phase

Status

Completed 3 Terminated 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Burkitt Lymphoma 1

Interventions

Cisplatin 453 Cyclophosphamide 315 Carboplatin 314 Radiotherapy 313 Paclitaxel 289 Capecitabine 285 Oxaliplatin 278 Gemcitabine 273 Docetaxel 271 Fluorouracil 245 apatinib 222 Drug Therapy 203 Bevacizumab 195 camrelizumab 186 Etoposide 177 Irinotecan 156 Doxorubicin 152 Dexamethasone 136 Leucovorin 135 Cytarabine 128 sintilimab 116 Pemetrexed 116 anlotinib 113 toripalimab 110 pembrolizumab 110 S 1 (combination) 107 Rituximab 107 Vincristine 105 Neoadjuvant Therapy 104 fludarabine 98

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01279707 2014-07-14

MARALL

Queen Mary University of London

Phase 1/2 Unknown

Burkitt Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡